vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and RESOURCES CONNECTION, INC. (RGP). Click either name above to swap in a different company.

PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $117.7M, roughly 1.4× RESOURCES CONNECTION, INC.). RESOURCES CONNECTION, INC. runs the higher net margin — -10.8% vs -82.0%, a 71.2% gap on every dollar of revenue. On growth, RESOURCES CONNECTION, INC. posted the faster year-over-year revenue change (-19.2% vs -22.7%). RESOURCES CONNECTION, INC. produced more free cash flow last quarter ($15.6M vs $-36.6M). Over the past eight quarters, PTC THERAPEUTICS, INC.'s revenue compounded faster (-11.5% CAGR vs -11.8%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

RGP, formerly known as Resources Global Professionals, is the operating arm of Resources Connection, Inc.. The company provides consulting services in the areas of finance & accounting, information management, governance, risk & compliance (GRC), human capital, legal & regulatory, corporate advisory & restructuring, strategic communications, and supply chain management. As of fiscal year ending May 28, 2016, the company employed 3,283 professionals in 68 offices in 20 countries around the wor...

PTCT vs RGP — Head-to-Head

Bigger by revenue
PTCT
PTCT
1.4× larger
PTCT
$164.7M
$117.7M
RGP
Growing faster (revenue YoY)
RGP
RGP
+3.6% gap
RGP
-19.2%
-22.7%
PTCT
Higher net margin
RGP
RGP
71.2% more per $
RGP
-10.8%
-82.0%
PTCT
More free cash flow
RGP
RGP
$52.2M more FCF
RGP
$15.6M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
PTCT
PTCT
Annualised
PTCT
-11.5%
-11.8%
RGP

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
PTCT
PTCT
RGP
RGP
Revenue
$164.7M
$117.7M
Net Profit
$-135.0M
$-12.7M
Gross Margin
37.1%
Operating Margin
-43.3%
-10.3%
Net Margin
-82.0%
-10.8%
Revenue YoY
-22.7%
-19.2%
Net Profit YoY
-104.8%
81.6%
EPS (diluted)
$-1.63
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
RGP
RGP
Q4 25
$164.7M
$117.7M
Q3 25
$211.0M
$120.2M
Q2 25
$178.9M
$139.3M
Q1 25
$1.2B
$129.4M
Q4 24
$213.2M
$145.6M
Q3 24
$196.8M
$136.9M
Q2 24
$186.7M
$148.2M
Q1 24
$210.1M
$151.3M
Net Profit
PTCT
PTCT
RGP
RGP
Q4 25
$-135.0M
$-12.7M
Q3 25
$15.9M
$-2.4M
Q2 25
$-64.8M
$-73.3M
Q1 25
$866.6M
$-44.1M
Q4 24
$-65.9M
$-68.7M
Q3 24
$-106.7M
$-5.7M
Q2 24
$-99.2M
$10.5M
Q1 24
$-91.6M
$2.5M
Gross Margin
PTCT
PTCT
RGP
RGP
Q4 25
37.1%
Q3 25
39.5%
Q2 25
40.2%
Q1 25
35.1%
Q4 24
38.5%
Q3 24
36.5%
Q2 24
40.2%
Q1 24
37.0%
Operating Margin
PTCT
PTCT
RGP
RGP
Q4 25
-43.3%
-10.3%
Q3 25
1.4%
-1.7%
Q2 25
-19.5%
-47.0%
Q1 25
82.5%
-38.4%
Q4 24
-76.2%
-52.7%
Q3 24
-27.7%
-3.5%
Q2 24
-21.5%
7.6%
Q1 24
-21.6%
2.8%
Net Margin
PTCT
PTCT
RGP
RGP
Q4 25
-82.0%
-10.8%
Q3 25
7.5%
-2.0%
Q2 25
-36.3%
-52.6%
Q1 25
73.7%
-34.0%
Q4 24
-30.9%
-47.2%
Q3 24
-54.2%
-4.2%
Q2 24
-53.1%
7.1%
Q1 24
-43.6%
1.7%
EPS (diluted)
PTCT
PTCT
RGP
RGP
Q4 25
$-1.63
$-0.38
Q3 25
$0.20
$-0.07
Q2 25
$-0.83
$-2.21
Q1 25
$10.04
$-1.34
Q4 24
$-0.85
$-2.08
Q3 24
$-1.39
$-0.17
Q2 24
$-1.29
$0.31
Q1 24
$-1.20
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
RGP
RGP
Cash + ST InvestmentsLiquidity on hand
$1.9B
$89.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$-205.3M
$194.6M
Total Assets
$2.9B
$289.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
RGP
RGP
Q4 25
$1.9B
$89.8M
Q3 25
$1.7B
$77.5M
Q2 25
$2.0B
$86.1M
Q1 25
$2.0B
$72.5M
Q4 24
$1.1B
$78.2M
Q3 24
$1.0B
$89.6M
Q2 24
$1.1B
$108.9M
Q1 24
$884.8M
$113.8M
Stockholders' Equity
PTCT
PTCT
RGP
RGP
Q4 25
$-205.3M
$194.6M
Q3 25
$-155.8M
$206.4M
Q2 25
$-206.5M
$207.1M
Q1 25
$-185.8M
$277.8M
Q4 24
$-1.1B
$325.7M
Q3 24
$-1.1B
$407.2M
Q2 24
$-980.2M
$418.8M
Q1 24
$-893.9M
$414.9M
Total Assets
PTCT
PTCT
RGP
RGP
Q4 25
$2.9B
$289.3M
Q3 25
$2.6B
$287.2M
Q2 25
$2.6B
$304.7M
Q1 25
$2.7B
$375.6M
Q4 24
$1.7B
$424.9M
Q3 24
$1.8B
$512.9M
Q2 24
$1.9B
$510.9M
Q1 24
$1.8B
$523.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
RGP
RGP
Operating Cash FlowLast quarter
$-34.3M
$15.9M
Free Cash FlowOCF − Capex
$-36.6M
$15.6M
FCF MarginFCF / Revenue
-22.3%
13.2%
Capex IntensityCapex / Revenue
1.4%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$702.3M
$24.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
RGP
RGP
Q4 25
$-34.3M
$15.9M
Q3 25
$-66.3M
$-7.8M
Q2 25
$-58.3M
$16.8M
Q1 25
$870.1M
$659.0K
Q4 24
$-30.0M
$1.8M
Q3 24
$-77.0M
$-309.0K
Q2 24
$-71.5M
$3.2M
Q1 24
$70.8M
$20.5M
Free Cash Flow
PTCT
PTCT
RGP
RGP
Q4 25
$-36.6M
$15.6M
Q3 25
$-69.7M
$-8.0M
Q2 25
$-59.6M
$16.5M
Q1 25
$868.4M
$238.0K
Q4 24
$-33.8M
$61.0K
Q3 24
$-77.5M
$-575.0K
Q2 24
$-78.8M
$3.0M
Q1 24
$61.2M
$20.4M
FCF Margin
PTCT
PTCT
RGP
RGP
Q4 25
-22.3%
13.2%
Q3 25
-33.1%
-6.6%
Q2 25
-33.3%
11.8%
Q1 25
73.8%
0.2%
Q4 24
-15.8%
0.0%
Q3 24
-39.4%
-0.4%
Q2 24
-42.2%
2.1%
Q1 24
29.1%
13.5%
Capex Intensity
PTCT
PTCT
RGP
RGP
Q4 25
1.4%
0.3%
Q3 25
1.6%
0.1%
Q2 25
0.7%
0.2%
Q1 25
0.1%
0.3%
Q4 24
1.8%
1.2%
Q3 24
0.3%
0.2%
Q2 24
4.0%
0.1%
Q1 24
4.6%
0.1%
Cash Conversion
PTCT
PTCT
RGP
RGP
Q4 25
Q3 25
-4.17×
Q2 25
Q1 25
1.00×
Q4 24
Q3 24
Q2 24
0.30×
Q1 24
8.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PTCT
PTCT

Segment breakdown not available.

RGP
RGP

US$93.7M80%
Non Us$24.0M20%

Related Comparisons